Cancer Cell International

Table 1 Statistics for BRF2 and clinicopathologic features in HCC patients

From: MALAT1/ mir-1-3p mediated BRF2 expression promotes HCC progression via inhibiting the LKB1/AMPK signaling pathway

	Expression			χ²	P value
	Total (n = 200)	Low(n = 100)	High(n = 100)	χ²	P value
Age (years)				0.501	0.479
≤ 50	95	45	50
> 50	105	55	50
Sex				0.038	0.845
Male	169	84	85
Female	31	16	15
Tumour size (cm)				37.729	< 0.001
≤ 5	133	87	46
> 5	67	13	54
Tumour number				1.452	0.228
1	157	82	75
≥ 2	43	18	25
Tumour differentiation				0.439	0.508
I-II	152	74	78
III-IV	48	26	22
Vascular invasion				3.712	0.054
No	159	85	74
Yes	41	15	26
Tumour capsule				2.642	0.104
Yes	71	30	41
No	129	70	59
Liver cirrhosis				0.567	0.451
No	34	15	19
Yes	166	85	81
AFP (ng/ml)				0.343	0.558
≤ 400	74	39	61
> 400	126	35	65
HBsAg				0.767	0.381
Negative	41	18	23
Positive	159	82	77
Recurrence				4.522	0.033
No	93	54	39
Yes	107	46	61

Back to article page

ISSN: 1475-2867

Contact us

General enquiries: journalsubmissions@springernature.com